IL-17 contributes to autoimmune hepatitis

Abstract

The role of interleukin-17 (IL-17) in autoimmune hepatitis (AIH) was investigated. A mouse model of experimental autoimmune hepatitis was established, and the syngeneic S-100 antigen emulsified in complete Freud’s adjuvant was injected intraperitoneally into adult male C57BL/6 mice. The IL-17 expression in serum and the livers of the mice models was detected by using ELISA and immunohistochemistry, respectively. IL-17 neutralizing antibody was used to study the biological effect of IL-17 in the experimental AIH. IL-17 neutralizing antibody in vivo administration alleviated the hepatic inflammation and ALT level in the AIH model. IL-17 in the peripheral blood mononuclear cells (PBMC) of AIH patients was measured by using real-time PCR method. The results showed that IL-17 level was significantly up-regulated in AIH patients and mice models. It was concluded that IL-17 contributed to the development of AIH and might be a potential therapeutic target of AIH.

Keywords

autoimmune hepatitis / interleukin-17

References

[1] LanR.Y., SalungaT.L., TsuneyamaK., et al.. Hepatic IL-17 responses in human and murine primary biliary cirrhosis. J Autoimmun, 2009, 32(1): 43-51

[2] LleoA., BattezzatiP.M., SelmiC., et al.. Is autoimmunity a matter of sex?. Autoimmun Rev, 2008, 7(8): 626-630

[3] GershwinM.E., MackayI.R., SturgessA., et al.. Identification and specificity of a cDNA encoding the 70 kd mitochondrial antigen recognized in primary biliary cirrhosis. J Immunol, 1987, 138(10): 3525-3531

[4] MackayI.R., WhittinghamS., FidaS., et al.. The peculiar autoimmunity of primary biliary cirrhosis. Immunol Rev, 2000, 174(1): 226-237

[5] ShimodaS., MiyakawaH., NakamuraM., et al.. CD4 T-cell autoreactivity to the mitochondrial autoantigen PDC-E2 in AMA-negative primary biliary cirrhosis. J Autoimmun, 2008, 31(2): 110-115

[6] AarvakT., ChabaudM., MiossecP., et al.. IL-17 is produced by some proinflammatory Th1/Th0 cells but not by Th2 cells. J Immunol, 1999, 162(3): 1246-1251

[7] AlbanesiC., ScarponiC., CavaniA., et al.. Interleukin-17 is produced by both Th1 and Th2 lymphocytes, and modulates interferon-gamma- and interleukin-4-induced activation of human keratinocytes. J Invest Dermatol, 2000, 115(1): 81-87

[8] Infante-DuarteC., HortonH.F., ByrneM.C., et al.. Microbial lipopeptides induce the production of IL-17 in Th cells. J Immunol, 2000, 165(11): 6107-6115

[9] MoletS., HamidQ., DavoineF., et al.. IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. J Allergy Clin Immunol, 2001, 108(3): 430-438

[10] FerrettiS., BonneauO., DuboisG.R., et al.. IL-17, produced by lymphocytes and neutrophils, is necessary for lipopolysaccharide-induced airway neutrophilia: IL-15 as a possible trigger. J Immunol, 2003, 170(4): 2106-2112

[11] HappelK.I., ZhengM., YoungE., et al.. Roles of Toll-like receptor 4 and IL-23 in IL-17 expression in response to Klebsiella pneumoniae infection. J Immunol, 2003, 170(9): 4432-4436

[12] MoseleyT.A., HaudenschildD.R., RoseL., et al.. Interleukin-17 family and IL-17 receptors. Cytokine Growth Factor Rev, 2003, 14(2): 155-174

[13] WongC.K., HoC.Y., LiE.K., et al.. Elevation of proinflammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus. Lupus, 2000, 9(8): 589-593

[14] HamzaouiK., HamzaouiA., GuemiraF., et al.. Cytokine profile in Behcet’s disease patients: relationship with disease activity. Scand J Rheumatol, 2002, 31(4): 205-210

[15] AntonysamyM.A., FanslowW.C., FuF., et al.. Evidence for a role of IL-17 in organ allograft rejection: IL-17 promotes the functional differentiation of dendritic cell progenitors. J Immunol, 1999, 162: 577-584

[16] MatsumotoK., KanmatsuseK.. Increased urinary excretion of interleukin-17 in nephrotic patients. Nephron, 2002, 91(2): 243-249

[17] WongC.K., HoC.Y., KoF.W.. Proinflammatory cytokines (IL-17, IL-6, IL-18 and IL-12) and Th cytokines (IFN-γ, IL-4, IL-10 and IL-13) in patients with allergic asthma. Clin Exp Immunol, 2001, 125(2): 177-183

[18] LockC., HermansG., PedottiR., et al.. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat Med, 2002, 8: 500-508

[19] YeP.F., RodriguezH., KanalyS., et al.. Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J Exp Med, 2001, 194(4): 519-528

[20] MaX., JiaY.T., QiuD.K.. Inhibition of p38 mitogen-activated protein kinase attenuates experimental autoimmune hepatitis: Involvement of nuclear factor kappa B. World J Gastroenterol, 2007, 13(31): 4249-4254

[21] NakaeS., KomiyamaY., NambuA., et al.. Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity, 2002, 17(3): 375-387

[22] AlvarezF., BergP.A., BianchiF.B., et al.. International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol, 1999, 31(5): 929-938

[23] KollsJ.K., LindeA.. Interleukin-17 family members and inflammation. Immunity, 2004, 21(4): 467-476

[24] MatsuzakiG., UmemuraM.. Interleukin-17 as an effector molecule of innate and acquired immunity against infections. Microbiol Immunol, 2007, 51(12): 1139-1147

[25] Acosta-RodriguezE.V., NapolitaniG., LanzavecchiaA., et al.. Interleukin 1 and 6 but not transforming growth factor are essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immunol, 2007, 8(9): 942-949

[26] WeaverC.T., HattonR.D., ManganP.R.. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol, 2007, 25: 821-852

[27] Amadi-ObiA., YuC.H., LiuX., et al.. Th17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1. Nat Med, 2007, 13(6): 711-718

[28] ZhangJ.Y., ZhangZ., LinF.. Interleukin-17-producing CD4⁺ T cells increase with severity of liver damage in patients with chronic hepatitis B. Hepatology, 2010, 51(1): 81-91

[29] LemmersA., MorenoC., GustotT., et al.. The interleukin-17 pathway is involved in human alcoholic liver disease. Hepatology, 2009, 49(2): 646-657

[30] RuthY.Z., LanA., ThucydidesL., et al.. Hepatic IL-17 responses in human and murine primary biliary cirrhosis. J Autoimmunol, 2009, 32(1): 43-51

[31] SilviaS.C., DieudonnéeT., IsabelleC.. Interleukin-17 is a negative regulator of established allergic asthma. J Exp Med, 2007, 203(12): 2715-2725